小程序掃碼下單
本網(wǎng)站銷售的所有產(chǎn)品僅用于工業(yè)應(yīng)用或者科學(xué)研究等非醫(yī)療目的，不可用于人類或動(dòng)物的臨床診斷或者治療，非藥用，非食用。
Recombinant Human Tyrosine kinase receptor A (HEK293-expressed)
英文名：
Cas號(hào)：
Cas號(hào)：
檢測(cè)信息查詢
| 貨號(hào) | 規(guī)格 | 貨期 | 庫(kù)存 | 價(jià)格 | 促銷價(jià) | 訂購(gòu) |
| 1308132819-10 μg | 0 | ￥3200 | ||||
| 1308132819-50 μg | 0 | ￥5800 |
| 別 名 | |
| Cas號(hào) | |
| M D L | |
| 分子式 | |
| 分子量 | |
| 產(chǎn)品參數(shù) | |
| 性狀 | Recombinant Human Tyrosine kinase receptor A (HEK293-expressed) 是神經(jīng)營(yíng)養(yǎng)素、神經(jīng)生長(zhǎng)因子的高親和力催化受體，調(diào)節(jié)神經(jīng)生長(zhǎng)因子的多種作用，包括神經(jīng)元分化和避免程序性細(xì)胞死亡。
Synonyms rHuTrkA; NTRK1; MTC; TRK ; 重組人酪氨酸激酶受體 A (HEK293細(xì)胞表達(dá)) Species Human Source HEK 293 Accession P04629 Gene ID 4914 Molecular Weight 65-85 kDa AA Sequence APCPDACCPH GSSGLRCTRD GALDSLHHLP GAENLTELYI ENQQHLQHLE LRDLRGLGEL RNLTIVKSGL RFVAPDAFHF TPRLSRLNLS FNALESLSWK TVQGLSLQEL VLSGNPLHCS CALRWLQRWE EEGLGGVPEQ KLQCHGQGPL AHMPNASCGV PTLKVQVPNA SVDVGDDVLL RCQVEGRGLE QAGWILTELE QSATVMKSGG LPSLGLTLAN VTSDLNRKNV TC Biological Activity The ED50 is <1 μg/mL as measured by TF-1 cells. Appearance Lyophilized powder. Formulation Lyophilized after extensive dialysis against PBS. Endotoxin Level <0.2 EU/μg, determined by LAL method. Reconstitution Reconstitute the lyophilized recombinant Human Tyrosine kinase receptor A (HEK293-expressed) (rHuTrkA) to 100 μg/mL using ddH2O or PBS. Storage & Stability Lyophilized recombinant Human Tyrosine kinase receptor A (HEK293-expressed) (rHuTrkA) is stored at -20°C. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer. It is recommended to freeze aliquots at -20°C or -80°C for extended storage. Shipping Room temperature in continental US; may vary elsewhere. Background Tyrosine kinase receptor A (TrkA) is the high affinity catalytic receptor for the neurotrophin, nerve growth factor (NGF), and mediates the multiple effects of NGF, which include neuronal differentiation and avoidance of programmed cell death. TrkA is originally cloned from a colon tumor; the cancer occurred via a translocation, which results in the activation of the TrkA kinase domain[1][2]. |
| 貯存 |
滬公網(wǎng)安備 31012002003054號(hào)